Molecular interactions of an alkaloid euchrestifoline as a new acetylcholinesterase inhibitor
Acetylcholinesterase (AChE) inhibitors are well established therapeutic agents for clinical management of Alzheimer's Diseases and other disorders associated with deficient cholinergic neurotransmission. In the current investigation, a new inhibitor has been reported for its significant AChE in...
Saved in:
Main Authors: | Fazal Ur Rehman (Author), Muhammad Faird Khan (Author), Inamullah Khan (Author), - Roohullah (Author) |
---|---|
Format: | Book |
Published: |
Bangladesh Pharmacological Society,
2013-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular docking of taraxerol acetate as a new COX inhibitor
by: Ubaid Ur Rehman, et al.
Published: (2013) -
In silico molecular mechanism of cannabigerol as a cyclooxygenase-2 inhibitor
by: Muhammad Abdullah Shah, et al.
Published: (2013) -
Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors
by: Zeynep Soyer, et al.
Published: (2017) -
New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors
by: Zi Han Loh, et al.
Published: (2021) -
Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
by: Yukio Ago, et al.
Published: (2011)